Medifast, Inc.
DE ˙ DB ˙ ES0162600003
9,98 € ↑0,03 (0,30%)
2026-06-04
DEL PRIS
SecurityDE:MDF / Medifast, Inc.
InstitutionCovestor Ltd
Latest Disclosed Ownership83 shares
Latest Disclosed Value $ 1
Covestor Ltd reports 40.68% increase in ownership of MDF / Medifast, Inc.

On May 5, 2026 - Covestor Ltd filed a 13F-HR form disclosing ownership of 83 shares of Medifast, Inc. (DE:MDF) valued at $683 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 59 shares of Medifast, Inc.. The current value of the position is $828 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F MEDIFAST COMMON 58470H101 83 24 40.68 0 0.0007
2026-02-06 2025-12-31 13F MEDIFAST COMMON 58470H101 59 30 103.45 0 0.0005
2025-10-30 2025-09-30 13F MEDIFAST COMMON 58470H101 29 -36 -55.38 0 0.0000
2025-08-11 2025-06-30 13F MEDIFAST COMMON 58470H101 65 -2 -2.99 0 0.0006
2025-05-12 2025-03-31 13F MEDIFAST COMMON 58470H101 67 -27 -28.72 0 0.0007
2025-02-13 2024-12-31 13F MEDIFAST COMMON 58470H101 94 -564 -85.71 0 0.0013
2024-11-01 2024-09-30 13F MEDIFAST COMMON 58470H101 658 203 44.62 0 0.0075
2024-08-09 2024-06-30 13F MEDIFAST COMMON 58470H101 455 160 54.24 0 0.0065
2024-05-10 2024-03-31 13F MEDIFAST COMMON 58470H101 295 155 110.71 0 0.0076
2024-02-09 2023-12-31 13F MEDIFAST COMMON 58470H101 140 55 64.71 0 0.0068
2023-11-13 2023-09-30 13F MEDIFAST COMMON 58470H101 85 -224 -72.49 0 0.0045
2023-08-11 2023-06-30 13F MEDIFAST COMMON 58470H101 309 308 30,800.00 0 0.0221
2023-05-15 2023-03-31 13F MEDIFAST COMMON 58470H101 1 -12 -92.31 0 -100.00
2023-02-14 2022-12-31 13F/A-1 MEDIFAST COMMON 58470H101 13 8 160.00 2 100.00 0.0016
2023-02-14 2022-12-31 13F MEDIFAST COMMON 58470H101 13 8 2 1.6309
2022-11-14 2022-09-30 13F MEDIFAST COMMON 58470H101 5 -12 -70.59 1 -66.67 0.0009
2022-08-10 2022-06-30 13F MEDIFAST COM 58470H101 17 -3 -15.00 3 0.00 0.0024
2022-05-13 2022-03-31 13F MEDIFAST COM 58470H101 20 -2 -9.09 3 -40.00 0.0020
2022-02-10 2021-12-31 13F MEDIFAST COM 58470H101 22 22 5 0.0070
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.